Leo Y. Luo

PRKACA mediates resistance to HER2-targeted therapy in breast cancer cells and restores anti-apoptotic signaling

Susan E. Moody, Anna C. Schinzel, Sharat Singh et al. · Oncogene · 2014 · 117 citations · Full text

Life Sciences, Cell Biology, Oncology +16

The Tyrosine Kinase Adaptor Protein FRS2 Is Oncogenic and Amplified in High-Grade Serous Ovarian Cancer

Leo Y. Luo, Eejung Kim, Hiu Wing Cheung et al. · Molecular Cancer Research · 2014 · 46 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Early outcomes of breast cancer patients treated with post-mastectomy uniform scanning proton therapy

Leo Y. Luo, John Cuaron, Lior Z. Braunstein et al. · Radiotherapy and Oncology · 2018 · 41 citations

Medicine, Radiation Oncology, Surgery +16

Are unsatisfactory outcomes after concurrent chemoradiotherapy for locally advanced non-small cell lung cancer due to treatment-related immunosuppression?

Maria Thor, Margaret Montovano, Alexandra Hotca et al. · Radiotherapy and Oncology · 2019 · 20 citations · Full text

Medicine, Oncology, Radiation Oncology +14

Socioeconomic inequality and omission of adjuvant radiation therapy in high-risk, early-stage endometrial cancer

Leo Y. Luo, Emeline Aviki, Anna Lee et al. · Gynecologic Oncology · 2021 · 18 citations · Full text

Medicine, Gynecology, Oncology +16